Glucosamine + Chondroitin vs Nattokinase

Mechanism

Glucosamine serves as a substrate for glycosaminoglycan (GAG) and proteoglycan biosynthesis in articular cartilage. It stimulates chondrocyte production of type II collagen and proteoglycans while inhibiting MMP-3 and aggrecanase enzymes that degrade cartilage matrix. Chondroitin sulfate provides osmotic swelling pressure in cartilage (water retention), inhibits complement-mediated inflammation, and downregulates NF-kB and IL-1beta in synoviocytes. Together they exert synergistic chondroprotective and mild anti-inflammatory effects.

Standard Dosing

1500mg glucosamine sulfate + 1200mg chondroitin sulfate daily

Timing

With meals, split into 2-3 doses. Full clinical benefit requires 8-12 weeks of consistent use.

Cycle Duration

ongoing (minimum 3 months to assess response)

Side Effects

• GI upset/nausea
• Heartburn
• Diarrhea or constipation
• Drowsiness (rare)
• Headache

Contraindications

• Shellfish allergy (if shellfish-derived glucosamine — use vegetarian/fungal source)
• Active bleeding with anticoagulant therapy

Best Stacking Partners

Mechanism

Nattokinase is a fibrinolytic serine protease extracted from natto (fermented soybeans). It directly degrades fibrin (the structural protein of blood clots) through four mechanisms: direct fibrinolysis, enhancement of endogenous tPA (tissue plasminogen activator) production, conversion of prourokinase to urokinase, and degradation of PAI-1 (plasminogen activator inhibitor-1). It also reduces blood viscosity and may inhibit ACE (angiotensin-converting enzyme), providing mild antihypertensive effects.

Standard Dosing

2000-4000 FU (fibrinolytic units) daily, equivalent to 100-200mg

Timing

On empty stomach, between meals or before bed. Morning and evening split dosing for 24-hour fibrinolytic coverage.

Cycle Duration

ongoing

Side Effects

• Easy bruising
• Nosebleeds
• GI upset
• Rare: serious bleeding events

Contraindications

• Active bleeding or bleeding disorders
• Scheduled surgery (discontinue 2+ weeks prior)
• Concurrent anticoagulant/antiplatelet therapy
• Hemorrhagic stroke history
• Soy allergy
• Active bleeding
• Bleeding disorders
• Pre-surgery (stop 2 weeks prior)
• Concurrent anticoagulation therapy without physician supervision

Best Stacking Partners